Compare SNX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNX | BIO |
|---|---|---|
| Founded | 1980 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 8.2B |
| IPO Year | 2003 | N/A |
| Metric | SNX | BIO |
|---|---|---|
| Price | $154.22 | $302.70 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $168.60 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 746.8K | 158.3K |
| Earning Date | 01-08-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | ★ 18.98 | N/A |
| EPS | ★ 9.21 | N/A |
| Revenue | ★ $60,973,509,000.00 | $2,557,500,000.00 |
| Revenue This Year | $7.25 | $1.62 |
| Revenue Next Year | $4.35 | $2.26 |
| P/E Ratio | $16.63 | ★ N/A |
| Revenue Growth | ★ 6.94 | N/A |
| 52 Week Low | $92.23 | $211.43 |
| 52 Week High | $167.76 | $373.69 |
| Indicator | SNX | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 51.29 | 42.26 |
| Support Level | $151.56 | $295.01 |
| Resistance Level | $155.82 | $307.07 |
| Average True Range (ATR) | 3.28 | 8.09 |
| MACD | -0.03 | -1.25 |
| Stochastic Oscillator | 49.73 | 22.23 |
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.